About
Our Story
Technology and Platforms
Our Approach
FasTCAR
TruUCAR
SMART CART
Manufacturing
Pipeline
Pipeline
Scientific Publications
Media Center
Press Releases
Media Report
|
EN
中文
Media Report
SCRIP : China CEO Interview: Gracell Aims To Enter US CAR-T Sector Through Partnerships, Faster Delivery
Nov 06, 2023
PharmaVoice :The 2023 PharmaVoice 100
Sep 19, 2023
Biocentury :CAR T collaborations: the next cross-border deal trend?
Sep 09, 2023
OncLive :GC012F Remains Safe, Generates Durable Responses in Relapsed/Refractory Myeloma
Jun 04, 2023
Targeted Oncology :GC012F Elicits Deep, Durable Responses in Relapsed/Refractory Multiple Myeloma
Jun 04, 2023
Endpoints News : Gracell gives sneak peek into leukemia CAR-T cell program ahead of EHA
May 12, 2023
Biocentury :Rapid CAR T manufacturing is about more than speed
Jan 21, 2023
BioCentury : Rapid CAR T manufacturing is about more than speed
Jan 20, 2023
PharmaVoice :Gracell Biotechnologies’ quest to unlock the CAR-T bottleneck
Jan 09, 2023
Fierce Pharma Asia :Gracell's CAR-T wows, showcasing a 100% tumor response rate for its BCMA-targeted CAR-T therapy
Dec 16, 2022
««
«
1
2
»
»»